When initial therapy is ineffective in patients with HABP/VABP or cSSSI due to S. aureus (MRSA or MSSA), choose VIBATIV (telavancin).
A treatment with:
- Consistently low MICs 2,3
- Bactericidal activity occurring within 6 – 8 hours and maintained up to 24 hours4
- High levels of tissue penetration5,6
The Centers for Disease Control and Prevention recommends daily reviews of initial antibiotic selection until a definitive diagnosis and treatment duration are established.7
